Ancestry informative genetic variants associated with tobacco metabolic and detoxification capacity measured by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) among smokers - Takeaways - MDSpire

Ancestry informative genetic variants associated with tobacco metabolic and detoxification capacity measured by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) among smokers

  • By

  • Oladimeji Lanade

  • Zhongxuan He

  • Yan Zhou

  • Elizabeth Blackman

  • Denise Gibbs

  • Sharon Harrison

  • Karthik Devarajan

  • Mark Andrake

  • Roland L. Dunbrack

  • Gerald Nkogbu

  • Aditi Wagh

  • Michael Slifker

  • Cherie Erkmen

  • Freda Patterson

  • Aditi Satti

  • Heather-Dawn Lawson-Myers

  • Robin Roberts

  • Don Mitchell

  • Jeffery C. Liu

  • Joel Erblich

  • Camille Ragin

  • July 14, 2026

Share

  • 1

    Tobacco use is the leading avoidable cause of cancer mortality, responsible for 26% of total cancer deaths globally in 2019.

  • 2

    Lung cancer incidence and mortality rates vary significantly among different demographics, particularly between Black and White males in the U.S.

  • 3

    Genetic ancestry factors may contribute to differences in tobacco-related cancer incidence between Black and White Americans.

  • 4

    The study investigates the association of genetic ancestry with tobacco metabolism efficiency, focusing on NNAL metabolites in smokers.

  • 5

    Participants in the study included current smokers aged 18 or older, recruited through community outreach and clinical settings.

Original Source(s)

Related Content